Portal versus systemic delivery of insulin: Immunologic benefits for pancreas transplantation

Current Opinion in Organ Transplantation

Volumn 7, Issue 2, 2002, Pages 180-184

  Philosophe, Benjamin ^a  

^a UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; GADOLINIUM; INSULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ANTIGEN PRESENTING CELL; ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; DONOR; EVIDENCE BASED MEDICINE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; PANCREAS TRANSPLANTATION; PORTAL VEIN; PORTAL VEIN BLOOD FLOW; SAMPLE SIZE; SYSTEMIC CIRCULATION;

EID: 0036059664     PISSN: 10872418     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075200-200206000-00013     Document Type: Article

References (36)

1. Paratopic segmental pancreas grafting: A technique with portal venous drainage
2. Pancreas transplantation. An initial experience with systemic and portal drainage of pancreatic allografts
3. Pancreas transplantation with portal venous drainage and enteric exocrine diversion: A new technique
4. Kidney-pancreas transplantation. The effect of portal versus systemic venous drainage of the pancreas on the lipoprotein composition
5. Results of pancreas transplantation with portal venous and enteric drainage
6. A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation
7. Immunogenic subcellular particles obtained from spleens of antigen-injected mice
8. Immunologic unresponsiveness produced in adult pigs by parenteral introduction of minute quantities of hapten or protein antigen
9. Hepatic suppression of sensitization to antigen absorbed into the portal vein
10. Impact of perioperative portal venous administration of donor lymphocytes on survival of rat cardiac allografts and renal grafts of the mongrel dog
11. The effect of portal venous tolerance on the survival of small bowel allografts in the rat
12. Small bowel transplantation: The effect of intraportal donor-specific transfusion 24 hours pre-transplantation and low-dose cyclosporine
13. Manipulation of xenogeneic skin and/or renal graft survival in the rat-mouse concordant combination by portal vein pretransplant transfusion
14. Portal vein administration of donor cells promotes peripheral allospecific hyperresponsiveness and graft tolerance
15. Evidence that donor spleen cells administered through the portal vein prolong the survival of cardiac allografts in rats
16. Speculation on the pathogenesis of prolonged cardiac allograft survival following portal venous inoculation of allogeneic cells
17. Enhanced survival of heterotopic rat heart allografts with portal venous drainage
18. Pretransplant portal venous administration of donor antigen and portal venous allograft drainage synergistically prolong rat cardiac allograft survival
19. Role of the liver in kidney allograft rejection in the rat
20. The effects of perioperative portal venous inoculation with donor lymphocytes on renal allograft survival in the rat. I. Specific prolongation of donor grafts and suppressor factor in the serum
21. A role of nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion
22. Adoptive transfer of unresponsiveness to allogeneic skin grafts with hepatic γδ+ T-cells
23. γδTCR+ hybridomas derived from mice preimmunized via the portal vein adoptively transfer increased skin allografts survival in vivo
24. A subset of γδTCR+ cells produce T-helper type 2 cytokines and regulate mouse skin graft rejection following portal venous pretransplant preimmunization
25. Outcome of Kupffer cell antigen presentation to a cloned murine Th1 lymphocyte depends on the inducibility of nitric oxide synthase by IFN-γ
26. Lymphocyte suppression by Kupffer cells prevents portal venous tolerance induction: A study of macrophage function after intravenous gadolinium
27. Are dendritic cells the key to liver transplantation tolerance?
28. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
29. Cross-presentation: A general mechanism for CTL immunity and tolerance
30. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival
31. Simultaneous liver and renal transplantation in man
32. Incidence of kidney and pancreas rejection following poral-enteric versus systemic-bladder pancreas-kidney transplantation
33. Patterns of acute rejection in portal-enteric versus systemic-bladder pancreas-kidney transplantation
34. Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: Clinical outcome of 40 consecutive transplantation recipients
35. The superiority of portal venous drainage over systemic venous drainage in pancreas transplantation; a retrospective study
36. Chronic rejection in renal transplantation recipients-risk factors and correlates